Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Obesity and renal disease.

Raymond D Adelman1

  • 1Phoenix Children's Hospital, Phoenix, Arizona 85006, USA. radelman@phoenixchildrens.com

Current Opinion in Nephrology and Hypertension
|May 1, 2002
PubMed
Summary

Obesity can lead to kidney disease, specifically obesity-associated proteinuria, characterized by specific biopsy findings and potential progression to end-stage renal disease. Early weight reduction is the most crucial treatment for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A young child with altered mental status.

Clinical pediatricsยท2002
See all related articles

Area of Science:

  • Nephrology
  • Obesity Medicine
  • Pathophysiology

Background:

  • Obesity is an epidemic, frequently complicating with hypertension and renal issues like proteinuria.
  • Obesity-associated proteinuria presents with focal glomerulosclerosis and glomerulomegaly, often without significant edema or hypertension, but can lead to end-stage renal disease.
  • Severe obesity exacerbates pre-existing kidney conditions or reduced renal mass.

Purpose of the Study:

  • To explore the pathophysiology of obesity-associated proteinuria.
  • To identify key factors contributing to kidney damage in obese patients.
  • To highlight therapeutic strategies for obesity-associated proteinuria.

Main Methods:

  • Review of clinical presentation and biopsy findings in patients with obesity-associated proteinuria.
  • Analysis of potential pathophysiological mechanisms including hyperfiltration and growth factor involvement.
  • Evaluation of therapeutic interventions.

Main Results:

  • Patients exhibit specific glomerular changes (focal glomerulosclerosis, glomerulomegaly) and can progress to kidney failure.
  • Pathophysiology involves hyperfiltration, glomerular hypertrophy, hyperlipidemia, and increased vasoactive/fibrogenic substances (e.g., angiotensin II, leptin).
  • Angiotensin-converting enzyme inhibition may offer temporary benefit.

Conclusions:

  • Obesity-associated proteinuria is a serious complication of obesity with distinct pathological features.
  • Multiple factors contribute to the kidney damage, including hemodynamic and hormonal changes.
  • Weight reduction is the primary therapeutic strategy for managing obesity-associated proteinuria.

Related Experiment Videos